Marco Marklewitz

Biographic Data

ID10018604
NAMEMarco Marklewitz
GIVEN NAMESMarco
FAMILY NAMEMarklewitz
SIGNATUREMARKLEWITZ M
AFFILIATIONSFIND
ORCID0000-0003-1828-8770
VERIFIEDYes
TOTAL WORKS4
TOTAL CITATIONS0
AUTHOR COUNT4
EDITOR COUNT0
FIRST PUBLICATION YEAR2023
LATEST PUBLICATION YEAR2026
H-INDEX0

  • Next-generation sequencing and bioinformatics capacity

    Open AccessAshley Bolding, Silvia Argimón et al.ARTICLEFrontiers in Public Health2026

    Next-generation sequencing (NGS) and bioinformatics are critical to infectious disease surveillance, outbreak detection and response, and the research and development of medical countermeasures. Achieving sustainable genomic surveillance requires countries to develop costed national strategies that integrate financial planning and budgeting across sequencing and bioinformatics activities. The genomics costing tool (GCT) was initially developed to…

  • Genomics costing tool

    Open AccessMarco Marklewitz, Alexandr Jaguparov et al.ARTICLEFrontiers in Public Health2025

    Next-generation sequencing (NGS) is crucial for monitoring and investigating infectious disease outbreaks, providing essential data for public health decisions. The COVID-19 pandemic has significantly expanded pathogen sequencing and bioinformatics capacities worldwide, creating an opportunity to leverage these advancements for other pathogens with pandemic and epidemic potential. In response to the need for a systematic cost estimation approach …

  • Investing in health preparedness, response and resilience

    Open AccessOluwatosin Akande, Babak Afrough et al.ARTICLEFrontiers in Public Health2024

    The world has seen unprecedented gains in the global genomic surveillance capacities for pathogens with pandemic and epidemic potential within the last 4 years. To strengthen and sustain the gains made, WHO is working with countries and partners to implement the Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential 2022–2032. A key technical product developed through these multi-agency collaborative efforts is a …

  • Strengthening pathogen genomic surveillance for health emergencies

    Open AccessOluwatosin Akande, Lisa L Carter et al.ARTICLEFrontiers in Public Health2023

    The onset of the COVID-19 pandemic triggered a rapid scale-up in the use of genomic surveillance as a pandemic preparedness and response tool. As a result, the number of countries with in-country SARS-CoV-2 genomic sequencing capability increased by 40% from February 2021 to July 2022. The Global Genomic Surveillance Strategy for Pathogens with Pandemic and Epidemic Potential 2022–2032 was launched by the World Health Organization (WHO) in March …